<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; APINACA; AB-FUBINACA; 5F-AMB; 5F-MDMB-PICA; 4-F-MDMB-BINACA; 4-CMC; N-ethylhexedrone; alpha-PHP; DOC; Crotonyl Fentanyl; Valeryl Fentanyl; Flualprazolam; Etizolam; and 8 Additional Preparations Listed in Schedule III of the 1961 Single Convention on Narcotic Drugs; Request for Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; APINACA; AB-FUBINACA; 5F-AMB; 5F-MDMB-PICA; 4-F-MDMB-BINACA; 4-CMC; N-ethylhexedrone; alpha-PHP; DOC; Crotonyl Fentanyl; Valeryl Fentanyl; Flualprazolam; Etizolam; and 8 Additional Preparations Listed in Schedule III of the 1961 Single Convention on Narcotic Drugs; Request for Comments</h1>
    <p class="timestamp">Published: 2019-09-10 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of 21 drug substances. These comments will be considered in preparing a response from the United States to the World Health Organization (WHO) regarding the abuse liability and diversion of these drugs. WHO will use this information to consider whether to recommend tha...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2019-19492</p>
    <p><strong>Publication Date:</strong> 2019-09-10</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2019/09/10/2019-19492/international-drug-scheduling-convention-on-psychotropic-substances-single-convention-on-narcotic">https://www.federalregister.gov/documents/2019/09/10/2019-19492/international-drug-scheduling-convention-on-psychotropic-substances-single-convention-on-narcotic</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2019-19492</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
